Connecting you to content on EBSCOhost

Works matching IS 20564538 AND DT 2015 AND VI 1 AND IP 3

Results: 7

1

Issue information.

Published in:: Journal of Pathology: Clinical Research, 2015, v. 1, n. 3, p. i, doi. 10.1002/cjp2.24
Publication type:: Article

2

Increased proliferation in atypical hyperplasia/endometrioid intraepithelial neoplasia of the endometrium with concurrent inactivation of ARID1A and PTEN tumour suppressors.

Published in:

Journal of Pathology: Clinical Research, 2015, v. 1, n. 3, p. 186, doi. 10.1002/cjp2.22

By:

Ayhan, Ayse;
Mao, Tsui‐Lien;
Suryo Rahmanto, Yohan;
Zeppernick, Felix;
Ogawa, Hiroshi;
Wu, Ren‐Chin;
Wang, Tian‐Li;
Shih, Ie‐Ming

Publication type:

Article

3

In‐depth molecular profiling of the biphasic components of uterine carcinosarcomas.

Published in:

Journal of Pathology: Clinical Research, 2015, v. 1, n. 3, p. 173, doi. 10.1002/cjp2.18

By:

McConechy, Melissa K.;
Hoang, Lien N.;
Chui, Michael Herman;
Senz, Janine;
Yang, Winnie;
Rozenberg, Nirit;
Mackenzie, Robertson;
McAlpine, Jessica N.;
Huntsman, David G.;
Clarke, Blaise A.;
Gilks, Cyril Blake;
Lee, Cheng‐Han

Publication type:

Article

4

A 12‐gene signature to distinguish colon cancer patients with better clinical outcome following treatment with 5‐fluorouracil or FOLFIRI.

Published in:

Journal of Pathology: Clinical Research, 2015, v. 1, n. 3, p. 160, doi. 10.1002/cjp2.17

By:

Paquet, Eric R.;
Cui, Jing;
Davidson, David;
Pietrosemoli, Natalia;
Hassan, Houssein Hajj;
Tsofack, Serges P.;
Maltais, Annie;
Hallett, Michael T.;
Delorenzi, Mauro;
Batist, Gerald;
Aloyz, Raquel;
Lebel, Michel

Publication type:

Article

5

Cancer‐testis antigens PRAME and NY‐ESO‐1 correlate with tumour grade and poor prognosis in myxoid liposarcoma.

Published in:

Journal of Pathology: Clinical Research, 2015, v. 1, n. 3, p. 144, doi. 10.1002/cjp2.16

By:

Iura, Kunio;
Kohashi, Kenichi;
Hotokebuchi, Yuka;
Ishii, Takeaki;
Maekawa, Akira;
Yamada, Yuichi;
Yamamoto, Hidetaka;
Iwamoto, Yukihide;
Oda, Yoshinao

Publication type:

Article

6

ReadMax—a novel reading and scoring approach for EGFR gene copy number to predict therapeutic benefit of erlotinib treatment in EGFR wild‐type non‐small‐cell lung cancer.

Published in:

Journal of Pathology: Clinical Research, 2015, v. 1, n. 3, p. 134, doi. 10.1002/cjp2.15

By:

Moecks, Joachim;
Soulières, Denis;
Klughammer, Barbara

Publication type:

Article

7

The prognosis of MYC translocation positive diffuse large B‐cell lymphoma depends on the second hit.

Published in:

Journal of Pathology: Clinical Research, 2015, v. 1, n. 3, p. 125, doi. 10.1002/cjp2.10

By:

Clipson, Alexandra;
Barrans, Sharon;
Zeng, Naiyan;
Crouch, Simon;
Grigoropoulos, Nicholas F.;
Liu, Hongxiang;
Kocialkowski, Sylvia;
Wang, Ming;
Huang, Yuanxue;
Worrillow, Lisa;
Goodlad, John;
Buxton, Jenny;
Neat, Michael;
Fields, Paul;
Wilkins, Bridget;
Grant, John W.;
Wright, Penny;
EI‐Daly, Hesham;
Follows, George A.;
Roman, Eve

Publication type:

Article